Data as of 10:28am ET
| +0.0026 / +0.46%|
The 2 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 1.85, with a high estimate of 2.50 and a low estimate of 1.20. The median estimate represents a +229.18% increase from the last price of 0.56.
The current consensus among 2 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.